Growth-hormone secretagogue
Ipamorelin
Synthetic pentapeptide
A selective ghrelin/GHS-R1a agonist studied for growth-hormone-pulse research with minimal cross-activity at cortisol/prolactin pathways.
Ipamorelin selectively activates the growth-hormone secretagogue receptor (GHS-R1a) without measurable activity at receptors associated with cortisol, prolactin, or ACTH release. That selectivity is the experimental signature distinguishing it from earlier secretagogues such as GHRP-2 and GHRP-6.
Common research areas
- GHS-R1a selectivity assays
- GH-pulse / secretagogue research
- Comparative receptor-binding studies
Watch
CJC-1295 + Ipamorelin: The Classic Stack
Dr. Ashley FroeseYouTube ↗
In our catalog
Ipamorelin 10 mg · $60 CAD · ≥99.8% HPLC
Related compounds
Further reading
Selected references
- 1. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol, 1998. PMID 9849822
- 2. The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation. Growth Horm IGF Res, 2001. PMID 11735244
- 3. The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin. Physiol Behav, 2024. PMID 39043357
For laboratory research use only. Reference information, not usage guidance or dosing advice.